The Market for Pharmaceuticals

Peter Zweifel (), Friedrich Breyer and Mathias Kifmann ()
Additional contact information
Peter Zweifel: University of Zurich
Mathias Kifmann: University of Augsburg

Chapter 12 in Health Economics, 2009, pp 401-428 from Springer

Abstract: Abstract One cannot possibly imagine present-day health care without pharmaceuticals. There are at least three reasons for this statement. (1) Pharmaceuticals represent a form of therapy that does not involve injuring or removing organs while permitting causal treatment (not only aimed at alleviating symptoms) in several instances. Chemotherapy, employed in the treatment of tuberculosis, is the historic example of such causal treatment; vaccination against the AIDS virus may become a future example.

Keywords: European Union; Marginal Cost; Consumer Surplus; Reference Price; Price Competition (search for similar items in EconPapers)
Date: 2009
References: Add references at CitEc
Citations:

There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:sprchp:978-3-540-68540-1_12

Ordering information: This item can be ordered from
http://www.springer.com/9783540685401

DOI: 10.1007/978-3-540-68540-1_12

Access Statistics for this chapter

More chapters in Springer Books from Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().